Issued: February 2012
The UK National Institute for Health and Clinical Excellence (NICE) technology
appraisal recommends Pharmalgen as an option for the treatment of
IgE-mediated bee and wasp venom allergy in people who have had a severe
systemic reaction to bee or wasp venom or a moderate systemic reaction to bee or wasp venom and who have one or more of the following: a raised baseline serum tryptase, a high risk of future stings or anxiety about future stings. The treatment should be initiated and monitored in a specialist centre
experienced in venom immunotherapy.